GlassScriptPhysician profile
Ivan Todorov Stoev
NPI 1730119595
$803.71
in general payments reported to CMS, 2019-2025
10 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2021: $34.82 · 2022: $27.48 · 2023: $40.08 · 2024: $177 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $340.15 | 2019 | |
| Stryker Corporation | $272.91 | 2024-2025 | Ozark Cervical Plate System, Direct Inject, Adherus Autospray Dural Sealant |
| Nuvasive, INC. | $40.08 | 2023 | Simplify Cervical Artificial Disc |
| Vb Spine LLC | $30.74 | 2025 | Capri Corpectomy Cage System |
| Bioventus LLC | $27.48 | 2022 | |
| Orthofix Medical, INC. | $21.97 | 2019 | |
| Intrinsic Therapeutics | $19.16 | 2021 | |
| Integra Lifesciences Corporation | $17.80 | 2019 | |
| Medtronic, INC. | $17.76 | 2025 | Stealthstation S8 Platform |
| Clarus Therapeutics INC. | $15.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Stoev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.